D-dimer-to-eGFR ratio is associated with multidimensional disease burden in hospitalized patients with gout

Background Clinical gout burden encompasses recurrent flares, polyarticular involvement, and tophus formation, while renal dysfunction further complicates disease management. This study investigated whether the D-dimer-to-estimated glomerular filtration rate (eGFR) ratio (DEGR), integrating fibrin turnover and renal function, provides complementary information on multidimensional gout burden beyond its individual components. Methods This retrospective single-center study included 422 hospitalized patients with gout, chronologically divided into a discovery cohort ( n = 296) and a temporal validation cohort ( n = 126). The primary outcomes were tophaceous gout and high multidimensional disease burden, defined by at least two of three features: tophi, ≥4 annual flares, and ≥4 affected joints. Associations were assessed using correlation and multivariable regression analyses, and discrimination was evaluated using receiver operating characteristic curves. Results DEGR correlated with gout duration, annual flare frequency, affected-joint count, tophaceous gout, and high burden (all P < 0.001). In fully adjusted models, each 1-standard-deviation increase in log 2 -transformed DEGR was associated with tophaceous gout (OR, 1.52; 95% CI, 1.16–2.01) and high burden (OR, 2.24; 95% CI, 1.66–3.02). DEGR discriminated high burden with an AUC of 0.684 (95% CI, 0.632–0.735), modestly exceeding D-dimer (0.660) and lower eGFR (0.599). Validation-cohort AUCs were 0.677 for tophaceous gout and 0.665 for high burden. Higher DEGR was also associated with greater systemic inflammation, longer hospitalization, and higher costs. Conclusion DEGR may provide complementary information on multidimensional gout burden by integrating coagulation-related and renal measures. Its potential role as an adjunctive marker warrants prospective multicenter validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-19
DOI
https://doi.org/10.3389/fmed.2026.2013579
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

D-dimer-to-eGFR ratio is associated with multidimensional disease burden in hospitalized patients with gout

Gui-Chen Ling, Lan Luo, Min Xiao, Shu-Juan Chen et al.
Frontiers in Medicine
Gout, Hyperuricemia, Uric Acid
article

D-dimer-to-eGFR ratio is associated with multidimensional disease burden in hospitalized patients with gout

Gui-Chen Ling, Lan Luo, Min Xiao, Shu-Juan Chen, Hao-Jie Zhong, Zhi-Ling Li, Jing-Jing Xie, Jian-Yong Zhang, Dan Tao
article en

Abstract

Background Clinical gout burden encompasses recurrent flares, polyarticular involvement, and tophus formation, while renal dysfunction further complicates disease management. This study investigated whether the D-dimer-to-estimated glomerular filtration rate (eGFR) ratio (DEGR), integrating fibrin turnover and renal function, provides complementary information on multidimensional gout burden beyond its individual components. Methods This retrospective single-center study included 422 hospitalized patients with gout, chronologically divided into a discovery cohort ( n = 296) and a temporal validation cohort ( n = 126). The primary outcomes were tophaceous gout and high multidimensional disease burden, defined by at least two of three features: tophi, ≥4 annual flares, and ≥4 affected joints. Associations were assessed using correlation and multivariable regression analyses, and discrimination was evaluated using receiver operating characteristic curves. Results DEGR correlated with gout duration, annual flare frequency, affected-joint count, tophaceous gout, and high burden (all P < 0.001). In fully adjusted models, each 1-standard-deviation increase in log 2 -transformed DEGR was associated with tophaceous gout (OR, 1.52; 95% CI, 1.16–2.01) and high burden (OR, 2.24; 95% CI, 1.66–3.02). DEGR discriminated high burden with an AUC of 0.684 (95% CI, 0.632–0.735), modestly exceeding D-dimer (0.660) and lower eGFR (0.599). Validation-cohort AUCs were 0.677 for tophaceous gout and 0.665 for high burden. Higher DEGR was also associated with greater systemic inflammation, longer hospitalization, and higher costs. Conclusion DEGR may provide complementary information on multidimensional gout burden by integrating coagulation-related and renal measures. Its potential role as an adjunctive marker warrants prospective multicenter validation.

Frontiers in MedicineVol. 13
Guangzhou University of Chinese Medicine (CN), Shenzhen Traditional Chinese Medicine Hospital (CN)
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon